天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

curromycin A

curromycin A Struktur
97412-76-5
CAS-Nr.
97412-76-5
Englisch Name:
curromycin A
Synonyma:
Curromycin;curromycin A;4,6,8-Decatrienamide, 3-hydroxy-N-[(2E,4E)-6-hydroxy-9-[8-hydroxy-1-(methoxymethyl)-5,7-dimethyl-3,6-dioxo-2-oxa-5-azaspiro[3.4]oct-8-yl]-9-methoxy-7-methyl-2,4-nonadien-1-yl]-2,2,4-trimethyl-10-(2-methyl-5-oxazolyl)-, (4Z,6Z,8E)-;(4E,6E,8E)-3-hydroxy-N-[(2E,4E)-6-hydroxy-9-[8-hydroxy-1-(methoxymethyl)-5,7-dimethyl-3,6-dioxo-2-oxa-5-azaspiro[3.4]octan-8-yl]-9-methoxy-7-methylnona-2,4-dienyl]-2,2,4-trimethyl-10-(2-methyl-1,3-oxazol-5-yl)deca-4,6,8-trienamide
CBNumber:
CB01331477
Summenformel:
C38H55N3O10
Molgewicht:
713.86
MOL-Datei:
97412-76-5.mol

curromycin A Eigenschaften

Siedepunkt:
898.4±65.0 °C(Predicted)
Dichte
1.23±0.1 g/cm3(Predicted)
pka
11.47±0.60(Predicted)

Sicherheit

curromycin A Chemische Eigenschaften,Einsatz,Produktion Methoden

curromycin A Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


curromycin A Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 3)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
BOC Sciences 1-631-485-4226; 16314854226
info@bocsci.com United States 14055 65
Zhejiang Huida Biotech Co., LTD 0571-89903882 13626641628
jiangnan@huidabiotech.com China 3656 58
Zhejiang Huida Biotech Co., LTD 0571-0571-89903882 15990081639
sunshixuan@huidabiotech.com China 3705 58

  • curromycin A
  • Curromycin
  • (4E,6E,8E)-3-hydroxy-N-[(2E,4E)-6-hydroxy-9-[8-hydroxy-1-(methoxymethyl)-5,7-dimethyl-3,6-dioxo-2-oxa-5-azaspiro[3.4]octan-8-yl]-9-methoxy-7-methylnona-2,4-dienyl]-2,2,4-trimethyl-10-(2-methyl-1,3-oxazol-5-yl)deca-4,6,8-trienamide
  • 4,6,8-Decatrienamide, 3-hydroxy-N-[(2E,4E)-6-hydroxy-9-[8-hydroxy-1-(methoxymethyl)-5,7-dimethyl-3,6-dioxo-2-oxa-5-azaspiro[3.4]oct-8-yl]-9-methoxy-7-methyl-2,4-nonadien-1-yl]-2,2,4-trimethyl-10-(2-methyl-5-oxazolyl)-, (4Z,6Z,8E)-
  • 97412-76-5
  • C38H55N3O10
Copyright 2019 ? ChemicalBook. All rights reserved